{"title":"Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform","authors":"Andrew Mancini","doi":"10.18609/cgti.2023.100","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell & gene therapy insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18609/cgti.2023.100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0